share_log

HC Wainwright & Co. Reiterates Buy on AcelRx Pharmaceuticals, Maintains $5 Price Target

Benzinga ·  Dec 7, 2023 05:45

HC Wainwright & Co. analyst Ed Arce reiterates AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment